Prevention of Mast Cell Activation Disorder-Associated Clinical Sequelae of Excessive Prostaglandin D2 Production
The DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Patients with systemic mastocytosis have increased numbers of mast cells in the bone marrow and other organs, such as the liver, spleen, gastrointestinal tract and skin. Symptoms result from the local and remote effects of mediator release from mast cells and from the local effects of increased mast cell numbers in various organs. Patients with mast cell activation experience many of the same clinical symptoms as do patients with systemic mastocytosis from chronic or spontaneous release of mast cell mediators. We report 4 patients with mast cell activation symptoms from selective release of prostaglandin (PG) D(2), but not histamine, and their improvement with aspirin therapy. METHODS: Bone marrow biopsy specimens obtained from 4 patients with symptoms suggestive of mastocytosis were examined by tryptase immunostaining. Baseline levels of serum tryptase and urinary 11beta-PGF(2)(alpha) and N-methylhistamine were obtained. In 2 of the 4 patients, urinary 11beta-PGF(2)(alpha) and N-methylhistamine samples were also measured during acute symptoms. RESULTS: Baseline increase in urinary excretion of the PGD(2) metabolite 11beta-PGF(2)(alpha) was found in 2 patients. In the remaining 2 patients, baseline levels of urinary 11beta-PGF(2)(alpha) and N-methylhistamine were normal, but during acute symptoms, the excretion of 11beta-PGF(2)(alpha) increased markedly. Treatment with aspirin resulted in normalization of 11beta-PGF(2)(alpha) excretion in the 2 patients with elevated baseline levels and in prevention of symptoms in all 4 patients. CONCLUSIONS: These results suggest that mast cell activation may be manifested by a selective excessive release of PGD(2). These patients respond to administration of aspirin but not to antihistamines.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“By contrast, other MC-related markers are less speci fi c and less well (or not yet) validated.”
From Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review (2021) · cites this paper as [46]
In the citing paper
“Prostaglandin D2 (PGD2) is a well-known product of activated MCs.”
From Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review (2021) · cites this paper as [46]
In the citing paper
“limited data are available to establish cutoffs for a signi fi cant increase in the levels of these mediators that would qualify as reliable indicators of severe systemic MCA.”
From Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review (2021) · cites this paper as [46]
In the citing paper
“Mediators other than tryptase are less speci fi c for MCs and MCAS”
From Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review (2021) · cites this paper as [46]
Citations
Cites
Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis
Schwartz, L. B., Metcalfe, D. D., Miller, J. S., Earl, H., & Sullivan, T. (1987) · New England Journal of Medicine · doi:10.1056/nejm198706253162603 · Cited by 784 · cited 1×
“Serum tryptase values have been elevated in samples taken between 1 and 4 h after the precipitating event in 6 of 6 patients seen for anaphylaxis to various triggers [”
BackgroundEpidemiology of anaphylaxis in Olmsted County: A population-based study☆☆☆★★★
Yocum, M. W., Butterfield, J. H., Klein, J. S., Volcheck, G. W., Schroeder, D. R., & Silverstein, M. D. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70392-1 · Cited by 451
Self-citationIncreased production of prostaglandin D2 in patients with systemic mastocytosis
Roberts, L. J., Sweetman, B. J., Lewis, R. A., Austen, K. F., & Oates, J. A. (1980) · New England Journal of Medicine · doi:10.1056/nejm198012113032405 · Cited by 423
Lin, R. Y., Schwartz, L. B., Curry, A., Pesola, G. R., Knight, R. J., Lee, H.-S., Bakalchuk, L., Tenenbaum, C., & Westfal, R. E. (2000) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2000.107600 · Cited by 277 · cited 1×
“On the basis of our experience with these cases, release of PGD 2 can occur independently of histamine as reflected in the disparate urinary levels of their metabolites. It is possible that excessive release of PGD 2 could be a sign of early mastocytosis before characteristic lesions appear in the bone marrow. No morp…”
BackgroundSheffer, A. L., & Austen, K. F. (1980) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(80)90056-1 · Cited by 276
Liston, T. E., & Roberts, L. J. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.18.6030 · Cited by 135
Sheffer, A. L., Tong, A. K. F., Murphy, G. F., Lewis, R. A., McFadden, E. R., & Austen, K. F. (1985) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(85)80021-x · Cited by 129
Biphasic systemic anaphylaxis: an inpatient and outpatient study.
Douglas, D. M., Sukenick, E., Andrade, W., & Brown, J. S. (1994) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(94)70044-3 · Cited by 126
Postprandial exercise-induced anaphylaxis
Novey, H. S., Fairshter, R. D., Salness, K., Simon, R. A., & Curd, J. G. (1983) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(83)90468-2 · Cited by 95
Monitoring mast cell activation by prostaglandin D2 in vivo
Dahlen, S.-E. (2004) · Thorax · doi:10.1136/thx.2004.026641 · Cited by 77
Prostaglandin D2 and histamine release in cold urticaria
Heavey, D. J., Kobza-Black, A., Barrow, S. E., Chappell, C. G., Greaves, M. W., & Dollery, C. T. (1986) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(86)90033-3 · Cited by 75
Exercise-induced urticaria, angioedema, and anaphylactoid episodes
Lewis, J. B., Lieberman, P., Treadwell, G., & Erffmeyer, J. E. (1981) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(81)90197-4 · Cited by 73
Idiopathic anaphylaxis: Classification, evaluation, and treatment of 123 patients
Wiggins, C. A., Dykewicz, M. S., & Patterson, R. (1988) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(88)90089-9 · Cited by 70
Ring, J., Arroyave, C. M., Frizler, M. J., & Tan, E. M. (1978) · PubMed · Cited by 69
Effects of intravenous infusions of prostaglandin D2 in man
Heavey, D. J., Lumley, P., Barrow, S. E., Murphy, M. B., Humphrey, P. P. A., & Dollery, C. T. (1984) · Prostaglandins · doi:10.1016/0090-6980(84)90033-9 · Cited by 66
Food-Dependent, Exercise-Induced Anaphylaxis
Buchbinder, E. M., Bloch, K. J., Moss, J., & Guiney, T. E. (1983) · JAMA · doi:10.1001/jama.1983.03340210071031 · Cited by 60
Koro, O., Dover, J., Francis, D. M., BLACK, A. K., Kelly, R. W., Barr, R. M., & Greaves, M. W. (1986) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1986.tb06654.x · Cited by 56
LASSER, E. C., Lang, J. H., LYON, S. G., & Hamblin, A. E. (1980) · Investigative Radiology · doi:10.1097/00004424-198011001-00004 · Cited by 48
Evaluation of Bronchospasm During Excretory Urography
Littner, M. R., Rosenfield, A. T., Ulreich, S., & Putman, C. E. (1977) · Radiology · doi:10.1148/124.1.17 · Cited by 43
Meta bisulfite challenge in patients with idiopathic anaphylaxis
Sonin, L., & Patterson, R. (1985) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(85)90014-4 · Cited by 39
Outcome of Prophylactic Therapy for Idiopathic Anaphylaxis
Wong, S., Yarnold, P. R., Yango, C., Patterson, R., & Harris, K. E. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-2-133 · Cited by 38
Pediatric idiopathic anaphylaxis: Experience with 22 patients
Ditto, A. M., Krasnick, J., Greenberger, P. A., Kelly, K. J., McGrath, K. G., & Patterson, R. (1997) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(97)70244-6 · Cited by 37
Roberts, L. J., Jw, T., & Oates, J. A. (1982) · PubMed · Cited by 36
Idiopathic anaphylaxis. A clinical summary of 175 patients
Wong, S., Dykewicz, M. S., & Patterson, R. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.150.6.1323 · Cited by 34
Anaphylactoid reactions to radiocontrast material
Erffmeyer, J. E., Siegle, R. L., & Lieberman, P. (1985) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(85)90079-x · Cited by 34
Carcinoid Syndrome and Disorders of Systemic Mast-Cell Activation Including Systemic Mastocytosis
Roberts, L. J. (1988) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30427-4 · Cited by 33
Shaffer, H. C., Parsons, D. J., Peden, D. B., & Morrell, D. S. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2005.06.012 · Cited by 32
Beasley, R. W., HOVEL, C., MANI, R., Robinson, C., Varley, J. G., & Holgate, S. T. (1988) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.1988.tb02914.x · Cited by 27
Contrast-protein interactions.
Ec, L., & Lang, J. H. (1970) · PubMed · Cited by 27
Sampson, S. E., Sampson, A. P., & Costello, J. (1997) · Thorax · doi:10.1136/thx.52.6.513 · Cited by 25
Elevated serum tryptase levels in a patient with protracted anaphylaxis.
Vinuya, R. Z., Simon, M. R., & Schwartz, L. B. (1994) · PubMed · Cited by 23
Disseminated Intravascular Coagulation Following Intravenous Pyelography
Zeman, R. K. (1977) · Investigative Radiology · doi:10.1097/00004424-197703000-00022 · Cited by 21
METABOLIC BASIS OF CONTRAST MATERIAL TOXICITY—STATUS 1971
Lasser, E. C. (1971) · American Journal of Roentgenology · doi:10.2214/ajr.113.3.414 · Cited by 21
Leukotriene C4 formation by enriched human basophil preparations from normal and asthmatic subjects
van der Donk, E. M. M., Blok, W. L., Kok, P. T. M., & Bruijnzeel, P. L. B. (1991) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/0952-3278(91)90138-u · Cited by 19
Respiratory Effects of Excretory Urography: A Preliminary Report
Rosenfield, A. T., Littner, M. R., Ulreich, S., Farmer, W. C., & Putman, C. E. (1977) · Investigative Radiology · doi:10.1097/00004424-197705000-00016 · Cited by 10
Research works printed but not linked: 1
- 10.1001%2fjama.250.21.2973 · doi:10.1001/jama.250.21.2973
Cited by
Valent, P., Akin, C., Arock, M., Brockow, K., Butterfield, J. H., Carter, M. C., Castells, M., Escribano, L., Hartmann, K., Lieberman, P., et al. (2012) · International Archives of Allergy and Immunology · doi:10.1159/000328760 · Cited by 654
Self-citationAnaphylaxis—a practice parameter update 2015
Lieberman, P., Nicklas, R. A., Randolph, C., Oppenheimer, J., Bernstein, D., Bernstein, J., Ellis, A., Golden, D. B. K., Greenberger, P., Kemp, S., et al. (2015) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2015.07.019 · Cited by 474
Álvarez-Twose, I., González de Olano, D., Sánchez-Muñoz, L., Matito, A., Esteban-López, M. I., Vega, A., Mateo, M. B., Alonso Díaz de Durana, M. D., de la Hoz, B., del Pozo Gil, M. D., et al. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.02.019 · Cited by 294
Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome
Valent, P., Akin, C., Bonadonna, P., Hartmann, K., Brockow, K., Niedoszytko, M., Nedoszytko, B., Siebenhaar, F., Sperr, W. R., Oude Elberink, J. N. G., et al. (2019) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2019.01.006 · Cited by 225
“Likewise, vascular instability may be triggered not only by histamine but also by prostaglandins (PGs) and/or leukotrienes (LTs) derived from activated MCs in the same patient, so that the reaction can be managed when administering histamine receptor blockers and PG/LT synthesis inhibitors and/or receptor blockers.(32…”
BackgroundSelf-citationValent, P., Escribano, L., Broesby‐Olsen, S., Hartmann, K., Grattan, C., Brockow, K., Niedoszytko, M., Nedoszytko, B., Oude Elberink, J. N. G., Kristensen, T., et al. (2014) · Allergy · doi:10.1111/all.12436 · Cited by 174
Self-citation
Metadata
- Authors
- Butterfield, J. H., & Weiler, C. R.
- Affiliations
- Mayo Clinic (US)
- Venue
- International Archives of Allergy and Immunology
- Publisher
- S. Karger AG
- Published
- 2008
- Volume
- 147
- Issue
- 4
- Pages
- 338-343
- ISSN
- 1018-2438 (ISSN-L)
- 1423-0097
- OpenAlex
- W2073764822
- Cited by
- 81
- References
- 36
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 7 · 2023: 7 · 2022: 4 · 2021: 6 · 2020: 3 · 2019: 9 · 2018: 5 · 2017: 2 · 2016: 7 · 2015: 5 · 2014: 7 · 2013: 6 · 2012: 2
- FWCI
- 0.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- International Archives of Allergy and Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Mast cells and histamine
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Keywords
- mast cell activation disorders, systemic mastocytosis, prostaglandin D2, aspirin therapy, N-methylhistamine, tryptase, mast cell mediators, symptom prevention
- MeSH terms
- Adult, Anaphylaxis, Aspirin, Female, Histamine Release, Humans, Male, Mast Cells, Mastocytosis, Middle Aged, Prostaglandin D2, Tryptases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.